Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities. Clin Cancer Res. 2019 02 15; 25(4):1147-1155.
View in:
PubMed
subject areas
Acid Anhydride Hydrolases
Cisplatin
Dose-Response Relationship, Drug
Drug-Related Side Effects and Adverse Reactions
Genome-Wide Association Study
Genotype
Hearing Loss
Humans
Membrane Proteins
Neoplasms
Polymorphism, Single Nucleotide
Quality of Life
Risk Factors
authors with profiles
Mary Dolan